Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

APOC1 anticorps (AA 35-48) (FITC)

APOC1 Reactivité: Humain Hôte: Lapin Polyclonal FITC
N° du produit ABIN7144417
  • Antigène Voir toutes APOC1 Anticorps
    APOC1 (Apolipoprotein C-I (APOC1))
    Épitope
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    AA 35-48
    Reactivité
    • 42
    • 2
    • 2
    • 2
    • 1
    • 1
    Humain
    Hôte
    • 34
    • 9
    • 5
    • 1
    Lapin
    Clonalité
    • 45
    • 4
    Polyclonal
    Conjugué
    • 27
    • 6
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp APOC1 est conjugé à/à la FITC
    Application
    Veuillez nous consulter SVP
     Réactivité croisée
    Humain
    Purification
    >95%, Protein G purified
    Immunogène
    Recombinant Human Apolipoprotein C-I protein (35-48aa)
    Isotype
    IgG
    Top Product
    Discover our top product APOC1 Anticorps primaire
  • Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    APOC1 (Apolipoprotein C-I (APOC1))
    Autre désignation
    APOC1 (APOC1 Produits)
    Synonymes
    anticorps Apo-CIB, anticorps ApoC-IB, anticorps ALPCI, anticorps LRRG04, anticorps APOC1, anticorps apoc1, anticorps apolipoprotein C1, anticorps apolipoprotein C-I, anticorps Apolipoprotein C-I, anticorps APOC1, anticorps Apoc1, anticorps apoc1
    Sujet

    Background: Inhibitor of lipoprotein binding to the low density lipoprotein (LDL) receptor, LDL receptor-related protein, and very low density lipoprotein (VLDL) receptor. Associates with high density lipoproteins (HDL) and the triacylglycerol-rich lipoproteins in the plasma and makes up about 10 % of the protein of the VLDL and 2 % of that of HDL. Appears to interfere directly with fatty acid uptake and is also the major plasma inhibitor of cholesteryl ester transfer protein (CETP). Binds free fatty acids and reduces their intracellular esterification. Modulates the interaction of APOE with beta-migrating VLDL and inhibits binding of beta-VLDL to the LDL receptor-related protein.

    Aliases: Apolipoprotein C-I (Apo-CI) (ApoC-I) (Apolipoprotein C1) [Cleaved into: Truncated apolipoprotein C-I], APOC1

    UniProt
    P02654
    Pathways
    Apoptose
Vous êtes ici:
Support technique